The Effective and Safety of Thalidomide in NTDT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02995707|
Recruitment Status : Unknown
Verified March 2017 by Xiao-Lin Yin, 303rd Hospital of the People's Liberation Army.
Recruitment status was: Recruiting
First Posted : December 16, 2016
Last Update Posted : March 22, 2017
|Condition or disease||Intervention/treatment||Phase|
|Thalassemia||Drug: Thalidomide||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Phase II Clinical Trials of Thalidomide in NTDT|
|Study Start Date :||September 2016|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||March 2018|
Experimental: thalidomide thalassemia
thalidomide:50mg/d p.o at bedtime
Other Name: fǎn yìng tíng
- The level of Hemoglobin [ Time Frame: 18 months ]All participants will complete the treatment for 18 months, the hemoglobin levels will be observed during the treatment.
- The effects of relative and absolute values of HbF [ Time Frame: 18 months ]The highest hemoglobin value will be observed,the value increased more than 20g/L defined as the marked effect, increased to 10~20g/L defined as effective, otherwise invalid.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02995707
|Contact: Liu Ch xu, President||0771 firstname.lastname@example.org|
|NO.3 Hospital of the Chinese People's Liberation Army||Recruiting|
|Nanjing, Guangxi, China, 530021|
|Contact: Li L zhu, Assistant 0771 2870303 email@example.com|
|Study Director:||Yin X Lin, director||NO.3 Hospital of the Chinese People's Liberation Army|